Amphoject (IV Infusion 50 mg vial)

Amphoject is indicated for the following: Empirical therapy for presumed fungal infection in febrile, neutropenic patients. Treatment of Cryptococcal Meningitis in HIV infected patients Treatment of patients with Aspergillus species, Candida species and/or Cryptococcus species infections refractory to Amphoject deoxycholate, or in patients where renal impairment or unacceptable toxicity precludes the use of Amphoject deoxycholate. Treatment of visceral leishmaniasis. In immunocompromised patients with visceral leishmaniasis treated with Amphoject, relapse rates were high following initial clearance of parasites * রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'

Add to cart